OmsætningOverskudP/EKUVEBITUdbytteAktierMarkedsværdiGældForpligtelserEgenkapitalAAQSMedarbejdereROEROAROCE

Ion Beam Applications AAQS 2024

Ion Beam Applications AAQS

5

Ion Beam Applications Udbytterendite

1,45 %

Ticker

IBAB.BR

ISIN

BE0003766806

WKN

914998

Ion Beam Applications har en aktuel AAQS på 5. En høj AAQS kan betragtes som et positivt tegn på, at virksomheden udvikler sig succesfuldt. Investorerne kan forvente, at virksomheden er på rette spor mod at skabe overskud. På den anden side er det vigtigt at betragte AAQS for aktien Ion Beam Applications i forhold til de opnåede overskud og sammenligne med andre virksomheder i samme branche. En høj AAQS er ikke en absolut garanti for en positiv fremtid. Det er kun på den måde, man kan få et komplet billede af virksomhedens præstationer. For bedre at kunne vurdere virksomhedens udvikling er det vigtigt at betragte AAQS i sammenligning med andre virksomheder i samme branche. Generelt bør investorer altid betragte en virksomheds AAQS i sammenhæng med andre nøgletal som overskud, EBIT, cash flow og andre for at træffe en velbaseret investeringsbeslutning.

Ion Beam Applications Aktienanalyse

Hvad gør Ion Beam Applications?

Ion Beam Applications SA ("IBA") is a leading provider of innovative solutions in the field of medical technology and particle accelerators. The company was founded in 1986 by Yves Jongen and is headquartered in Louvain-la-Neuve, Belgium, with branches and subsidiaries worldwide. IBA specializes in the manufacturing and operation of proton therapy systems and other radiation therapy devices used in the treatment of cancer and other diseases. The company has built over 50 proton therapy centers worldwide, including the first one in Louvain-la-Neuve, and is currently working on developing new solutions to further improve the effectiveness of radiation therapy. In recent years, IBA has expanded its business model to also target other areas such as industrial material analysis and semiconductor manufacturing. By utilizing its patented ion technology, the company can manufacture highly precise measuring instruments and process controls used in areas such as quality assurance, on-site analysis, and research. IBA's key products and services include: 1. Proton therapy systems: IBA offers a wide range of proton therapy systems, including compact and affordable systems, mobile systems, rotational units, and multipencil beam systems. These systems are used in hospitals and healthcare centers worldwide to treat cancer and other diseases. 2. Radiation therapy software and services: In addition to proton therapy systems, IBA also provides a variety of software solutions and services utilized by medical physicists and radiation therapists. These include dose calculation software, device planning software, quality control services, and training. 3. Industrial material analysis and process control devices: IBA manufactures a range of instruments and devices that can be used for material analysis and process control. These include X-ray fluorescence spectrometers for solid analysis, X-ray tubes for inspection of metallic and other materials, and electron beam sources for surface modification of materials. 4. Semiconductor technology products: IBA also offers a range of products and solutions for the semiconductor industry, including ion implantation systems for integrated circuit manufacturing and leading test solutions for semiconductor manufacturers. IBA remains a key player in the medical technology industry and others reliant on particle accelerator and ion-specific technologies. In addition to its outstanding quality and reliability, IBA is appreciated by its customers for providing advanced solutions tailored to their specific needs. With a team of over 1,500 employees and years of experience in the development and manufacturing of ion-accelerated systems, IBA is driving innovations in medical technology and other fields to create a better future for all. Ion Beam Applications ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Ofte stillede spørgsmål om Ion Beam Applications aktien

Aktiespareplaner tilbyder en attraktiv mulighed for investorer at opbygge formue på lang sigt. En af de største fordele er den såkaldte cost-average-effekt: Ved regelmæssigt at investere et fast beløb i aktier eller aktiefonde, køber man automatisk flere andele, når priserne er lave, og færre, når de er høje. Dette kan føre til en mere fordelagtig gennemsnitspris per andel over tid. Desuden giver aktiespareplaner også småinvestorer adgang til dyre aktier, da de kan deltage med små beløb. Den regelmæssige investering fremmer også en disciplineret investeringsstrategi og hjælper med at undgå følelsesladede beslutninger, som impulsiv køb eller salg. Derudover drager investorer fordel af den potentielle værdistigning af aktierne samt af udbytteudlodninger, der kan geninvesteres, hvilket forstærker renters rente effekten og dermed væksten af det investerede kapital.

Andere Kennzahlen von Ion Beam Applications

Vores aktieanalyse af Ion Beam Applications Omsætning-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Ion Beam Applications Omsætning. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: